Orthopediatrics (KIDS) Cash from Financing Activities (2016 - 2026)
Orthopediatrics has reported Cash from Financing Activities over the past 11 years, most recently at -$614000.0 for Q1 2026.
- For Q1 2026, Cash from Financing Activities fell 387.3% year-over-year to -$614000.0; the TTM value through Mar 2026 reached $23.5 million, down 56.17%, while the annual FY2025 figure was $24.0 million, 54.88% down from the prior year.
- Cash from Financing Activities for Q1 2026 was -$614000.0 at Orthopediatrics, down from -$417000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $108.3 million in Q3 2022 and troughed at -$4.3 million in Q2 2024.
- A 5-year average of $12.9 million and a median of -$36000.0 in 2023 define the central range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 390220.0% in 2024 and fell as far as 1491.67% in 2024.
- Year by year, Cash from Financing Activities stood at -$35000.0 in 2022, then soared by 26920.0% to $9.4 million in 2023, then tumbled by 105.76% to -$541000.0 in 2024, then increased by 22.92% to -$417000.0 in 2025, then tumbled by 47.24% to -$614000.0 in 2026.
- Business Quant data shows Cash from Financing Activities for KIDS at -$614000.0 in Q1 2026, -$417000.0 in Q4 2025, and -$282000.0 in Q3 2025.